084110 휴온스글로벌
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 2,987억원 (2026-06-30 기준)
- 첫 등장: 2026-06-09 (누적 1일)
- 태그: 매크로/바이오헬스 · 제약 · 주사제 · 히알루론산 · 필러 · 바이오
- 네이버 금융: 🔗
기업개요
- 동사는 1965년 설립하여 2016년 순수지주회사로 전환한 휴온스그룹의 지주회사임.
- 주요 종속회사로는 전문의약품 제조하는 휴온스, 히알루론산 필러 및 관절염치료제를 영위하는 휴메딕스, 보툴리눔 톡신 제조 및 판매하는 휴온스바이오파마가 있음.
- 동사는 자회사 경영지도와 상표권, 경영자문, 배당수익을 주요 수입원으로 하며, 팬젠과 바이오로제트 편입으로 바이오 및 건강기능식품 포트폴리오 확장하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 25,500 | 25,500 | ⚪ +0.00% | +0.00%p | ×0.6 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.1 | +0.0 | +1.1 | -0.1 |
| 2026-08-13 | 25,450 | 25,500 | 🔴 +0.20% | +0.79%p | ×0.9 | 🟢 외인 | +4.1억 | +4.1 | +0.0 | -0.0 | +0.0 | -3.8 | -0.3 |
| 2026-08-12 | 25,950 | 25,450 | 🔵 -1.93% | +1.35%p | ×1.2 | ⚫ 그외 | -1.3억 | -1.3 | +0.0 | +0.0 | -0.0 | -0.1 | +1.4 |
| 2026-08-11 | 25,200 | 25,950 | 🔴 +2.98% | +0.40%p | ×1.1 | 🟢 외인 | +2.1억 | +2.1 | +0.0 | -0.3 | +0.0 | -1.4 | -0.4 |
| 2026-08-10 | 25,100 | 25,200 | 🔴 +0.40% | -0.40%p | ×0.8 | 🟢 외인 | +4.4억 | +4.4 | +0.0 | +0.4 | +0.0 | -4.2 | -0.6 |
| 2026-08-07 | 25,500 | 25,100 | 🔵 -1.57% | +0.98%p | ×0.3 | 🟡 금투 | -0.1억 | -0.1 | +0.0 | +0.1 | +0.0 | -0.0 | +0.0 |
| 2026-08-06 | 24,900 | 25,500 | 🔴 +2.41% | +0.80%p | ×0.6 | 🟢 외인 | +3.4억 | +3.4 | +0.0 | +0.0 | +0.0 | -2.8 | -0.6 |
| 2026-08-05 | 24,700 | 24,900 | 🔴 +0.81% | -1.62%p | ×0.5 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.1 | +0.0 | +0.6 | -0.1 |
| 2026-08-04 | 23,400 | 24,700 | 🔴 +5.56% | -0.42%p | ×0.6 | 🟢 외인 | +2.5억 | +2.5 | +0.0 | -0.1 | +0.0 | -1.6 | -0.8 |
| 2026-08-03 | 22,250 | 23,400 | 🔴 +5.17% | -0.22%p | ×0.8 | 🟢 외인 | +1.7억 | +1.7 | +0.0 | +0.0 | +0.0 | -2.1 | +0.3 |
| 2026-07-31 | 21,150 | 22,250 | 🔴 +5.20% | -1.18%p | ×1.0 | 🟢 외인 | +2.9억 | +2.5 | +0.0 | -0.1 | +0.4 | -3.1 | +0.4 |
| 2026-07-30 | 21,000 | 21,150 | 🔴 +0.71% | +0.71%p | ×2.4 | 🟢 외인 | +5.7억 | +5.7 | +0.0 | -0.0 | -0.0 | -5.7 | +0.0 |
| 2026-07-29 | 22,150 | 21,000 | 🔵 -5.19% | +1.81%p | ×2.5 | ⚫ 그외 | -3.4억 | -4.0 | +0.0 | -0.1 | +0.6 | +1.4 | +2.2 |
| 2026-07-28 | 24,400 | 22,150 | 🔵 -9.22% | -1.02%p | ×1.7 | 🟢 외인 | +3.4억 | +2.9 | +0.0 | +0.0 | +0.5 | -3.4 | +0.1 |
| 2026-07-27 | 25,150 | 24,400 | 🔵 -2.98% | +0.60%p | ×1.3 | ⚫ 그외 | -0.6억 | -0.6 | +0.0 | -0.1 | +0.0 | -0.5 | +1.1 |
| 2026-07-24 | 25,500 | 25,150 | 🔵 -1.37% | +0.59%p | ×0.5 | ⚫ 그외 | -1.6억 | -1.6 | +0.0 | +0.0 | +0.0 | +0.7 | +0.9 |
| 2026-07-23 | 23,350 | 25,500 | ➖ 🔴 +9.21% | -1.50%p | ×1.2 | 🔻 개인 | -0.8억 | +0.1 | +0.0 | +0.0 | -0.8 | +0.8 | -0.1 |
| 2026-07-22 | 24,200 | 23,350 | 🔵 -3.51% | -1.86%p | ×0.8 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | -0.1 | +0.0 | +1.0 | +0.1 |
| 2026-07-21 | 24,600 | 24,200 | 🔵 -1.63% | +0.40%p | ×0.8 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | -0.0 | +0.0 | +0.8 | +0.0 |
| 2026-07-20 | 27,550 | 24,600 | 🔵 -10.71% | +0.91%p | ×1.2 | 🔻 개인 | -0.6억 | -1.5 | +0.0 | +0.0 | +0.9 | +2.2 | -1.7 |
| 2026-07-16 | 28,500 | 27,550 | 🔵 -3.33% | +0.53%p | ×0.8 | 🔻 개인 | -3.3억 | -3.3 | +0.0 | -0.0 | +0.0 | +3.3 | +0.1 |
| 2026-07-15 | 25,650 | 28,500 | 🔴 +11.11% | +0.58%p | ×1.1 | ⚫ 그외 | -1.1억 | -1.1 | +0.0 | +0.3 | +0.0 | -2.1 | +2.9 |
| 2026-07-14 | 26,150 | 25,650 | 🔵 -1.91% | -0.19%p | ×0.8 | 🟣 투신 | +0.9억 | +0.5 | +0.0 | +0.0 | +0.5 | -1.3 | +0.3 |
| 2026-07-13 | 27,200 | 26,150 | 🔵 -3.86% | +0.92%p | ×0.7 | 🔻 개인 | -2.6억 | -3.1 | +0.0 | +0.0 | +0.5 | +1.7 | +0.8 |
| 2026-07-10 | 26,550 | 27,200 | 🔴 +2.45% | +0.38%p | ×0.7 | ⚫ 그외 | +0.1억 | +0.1 | +0.0 | +0.2 | +0.0 | -1.1 | +0.8 |
| 2026-07-09 | 25,500 | 26,550 | 🔴 +4.12% | +0.00%p | ×0.8 | 🔻 개인 | -2.0억 | -2.2 | +0.0 | +0.0 | +0.2 | +1.3 | +0.7 |
| 2026-07-08 | 26,850 | 25,500 | 🔵 -5.03% | -4.10%p | ×1.0 | ⚫ 그외 | -1.6억 | -2.4 | +0.0 | -0.0 | +0.9 | +0.4 | +1.2 |
| 2026-07-07 | 25,500 | 26,850 | 🔴 +5.29% | -0.59%p | ×1.1 | 🟣 투신 | -0.9억 | -3.3 | +0.0 | -0.0 | +2.4 | +0.3 | +0.6 |
| 2026-07-06 | 25,150 | 25,500 | 🔴 +1.39% | -0.80%p | ×0.4 | 🔻 개인 | -2.4억 | -2.4 | +0.0 | +0.0 | +0.0 | +1.9 | +0.5 |
| 2026-07-03 | 24,050 | 25,150 | 🔴 +2.65% | -3.17%p | ×0.7 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | +0.0 | -0.8 | +0.1 |
| 2026-07-02 | 24,250 | 24,050 | 🔵 -0.82% | -1.85%p | ×0.6 | 🔻 개인 | -5.2억 | -4.6 | +0.0 | +0.0 | -0.6 | +4.5 | +0.7 |
| 2026-07-01 | 23,600 | 24,250 | 🔴 +2.75% | +0.42%p | ×0.7 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | +0.0 | +0.0 | -1.1 | +0.4 |
| 2026-06-30 | 24,450 | 23,600 | 🔵 -3.48% | +0.00%p | ×0.9 | 🔻 개인 | -4.4억 | -4.4 | +0.0 | +0.0 | +0.0 | +2.9 | +1.5 |
| 2026-06-29 | 22,700 | 24,450 | 🔴 +7.71% | +0.22%p | ×1.9 | 🟢 외인 | +11.8억 | +11.8 | +0.0 | -11.5 | +0.0 | -0.7 | +0.4 |
| 2026-06-26 | 23,600 | 22,700 | 🔵 -3.81% | +0.64%p | ×1.2 | ⚫ 그외 | -2.8억 | -2.8 | +0.0 | +1.8 | +0.0 | -1.5 | +2.5 |
| 2026-06-25 | 24,800 | 23,600 | 🔵 -4.84% | -0.40%p | ×0.6 | ⚫ 그외 | -1.6억 | -2.0 | +0.0 | -0.1 | +0.4 | +0.6 | +1.1 |
| 2026-06-24 | 22,700 | 24,800 | 🔴 +9.25% | +1.10%p | ×0.8 | ⚫ 그외 | -0.6억 | -0.6 | +0.0 | -0.0 | -0.7 | +1.3 | |
| 2026-06-23 | 24,350 | 22,700 | 🔵 -6.78% | -2.88%p | ×0.8 | 🟢 외인 | +3.8억 | +3.8 | -0.0 | -0.3 | -4.8 | +1.2 | |
| 2026-06-22 | 25,350 | 24,350 | 🔵 -3.94% | -0.98%p | ×0.5 | 🔻 개인 | -1.4억 | -1.4 | +0.0 | +0.3 | +1.3 | -0.2 | |
| 2026-06-19 | 26,600 | 25,350 | 🔵 -4.70% | +0.19%p | ×0.8 | ⚫ 그외 | -2.6억 | -2.6 | +0.0 | -0.0 | +0.9 | +1.7 | |
| 2026-06-18 | 27,600 | 26,600 | 🔵 -3.62% | +0.37%p | ×0.9 | ⚫ 그외 | -0.7억 | -0.7 | +0.0 | -0.5 | -4.0 | +5.2 | |
| 2026-06-17 | 27,050 | 27,600 | 🔴 +2.03% | +0.92%p | ×0.5 | 🔻 개인 | -2.3억 | -2.3 | -0.0 | +0.1 | +2.3 | -0.0 | |
| 2026-06-16 | 27,150 | 27,050 | 🔵 -0.37% | +0.73%p | ×0.3 | 🔻 개인 | -2.1억 | -2.1 | +0.0 | +0.0 | +2.0 | +0.1 | |
| 2026-06-15 | 27,800 | 27,150 | 🔵 -2.34% | +0.18%p | ×0.5 | 🔻 개인 | -2.2억 | -2.2 | +0.0 | -0.4 | +2.8 | -0.2 | |
| 2026-06-12 | 26,900 | 27,800 | 🔴 +3.35% | +1.68%p | ×0.5 | 🟡 금투 | +0.1억 | +0.1 | +0.0 | +0.4 | -0.5 | -0.0 | |
| 2026-06-11 | 26,350 | 26,900 | 🔴 +2.09% | +1.14%p | ×0.8 | 🟢 외인 | +2.6억 | +2.6 | +0.0 | -0.1 | -2.4 | -0.1 | |
| 2026-06-10 | 28,450 | 26,350 | 🔵 -7.38% | -1.76%p | ×0.6 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.0 | +0.6 | -0.1 | |
| 2026-06-09 | 25,500 | 28,450 | ➕ 🔴 +11.57% | +3.92%p | ×0.8 | 🟢 외인 | +3.1억 | +3.1 | +0.0 | -0.2 | -4.3 | +1.4 | |
| 2026-06-08 | 28,000 | 25,500 | 🔵 -8.93% | +1.43%p | ×0.8 | 🟢 외인 | +2.3억 | +2.3 | +0.0 | +0.2 | -2.3 | -0.3 | |
| 2026-06-05 | 28,700 | 28,000 | 🔵 -2.44% | -0.70%p | ×1.1 | 🟢 외인 | +7.4억 | +7.4 | +0.0 | +0.0 | -7.3 | -0.1 | |
| 2026-06-04 | 28,150 | 28,700 | 🔴 +1.95% | -3.38%p | ×0.6 | 🔻 개인 | -1.3억 | -1.3 | +0.0 | -0.0 | +1.5 | -0.2 | |
| 2026-06-02 | 29,600 | 28,150 | 🔵 -4.90% | -1.18%p | ×0.9 | 🟢 외인 | +10.7억 | +10.7 | +0.0 | -0.3 | -9.3 | -1.1 | |
| 2026-06-01 | 30,900 | 29,600 | 🔵 -4.21% | -0.97%p | ×0.8 | 🟢 외인 | +14.4억 | +14.4 | +0.0 | -1.7 | -10.5 | -2.1 | |
| 2026-05-29 | 32,400 | 30,900 | 🔵 -4.63% | -0.46%p | ×0.3 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.0 | +2.8 | -1.8 |
일자별 사유 (최신 위)
2026-07-23
- 사유: 중복상장 규제·SC플랫폼 재평가 기대
- 섹터 컨텍스트: KOSDAQ:제조 (smart +583억)
- 매크로 원인: 코스피·코스닥 급등장 속 개별 임상·M&A·주주환원 모멘텀이 겹치며 제약바이오 전반 강세 (보통)
2026-07-15
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +1,144억)
- 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)
2026-06-09
- 사유: 자회사 합병 주주환원책 확정·신주 26만주 현물배당
- 섹터 컨텍스트: KOSDAQ:제조 (smart +1,603억)
- 매크로 원인: 코스피·코스닥 급반등 동조 + 美당뇨학회 비만약·ADC 기술수출 K바이오 모멘텀, 개별 호재 가세 (보통)